1. Home
  2. List
Reference Patent

Reference - List

  • 12 Hits
  • Search Condition : Filter (MeSH = Programmed Cell Death 1 Receptor)
Species Resource Title
Human and Animal Cells LA-N-5(RCB0485) , T98G(RCB1954) , 10T1/2(RCB0247) , 293T(RCB2202) Rejuvenated iPSC-derived GD2-directed CART Cells Harbor Robust Cytotoxicity Against Small Cell Lung Cancer.
Human and Animal Cells HSC-2(RCB1945) , HSC-3(RCB1975) , HSC-4(RCB1902) Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancer.
Human and Animal Cells B16F10(RCB2630) PD-L1 antibody enhanced β-glucan antitumor effects via blockade of the immune checkpoints in a melanoma model.
Mice RBRC09497 Tumor-derived semaphorin 4A improves PD-1-blocking antibody efficacy by enhancing CD8+ T cell cytotoxicity and proliferation.
DNA material CSII-CMV-MCS-IRES2-Bsd (RDB04385) CD70 and PD-L1 (CD274) co-expression predicts poor clinical outcomes in patients with pleural mesothelioma.
Mice RBRC02142 Conjugation of human serum albumin and flucloxacillin provokes specific immune response in HLA-B*57:01 transgenic mice.
Human and Animal Cells PC-9(RCB4455) Influence of Nivolumab for Intercellular Adhesion Force between a T Cell and a Cancer Cell Evaluated by AFM Force Spectroscopy.
Mice RBRC01346 The critical role of CD4+ T cells in PD-1 blockade against MHC-II-expressing tumors such as classic Hodgkin lymphoma.
DNA material PD-1 (cDNA#7) (RDB01290) Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.
Human and Animal Cells PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells.
Mice RBRC00904 Chemotherapy rescues tumor-driven aberrant CD4+ T-cell differentiation and restores an activated polyfunctional helper phenotype.
Mice RBRC02142 Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression.